Clinical Trial Update: F-18-OMFD-PET for Radiotherapy Treatment Planning and Evaluation of Early Therapy Response

View source ↗

Summary

A clinical trial evaluating F-18-OMFD-PET for radiotherapy treatment planning and early therapy response in brain tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Tumor

Drugs mentioned

• F-18-OMFD-PET (fluorine-18 OMFD radiotracer)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Brain Tumor | Status: TERMINATED